Abstract:Muhammad Fauzan Meidika Subagdja, 1, &ast Adhi Kristianto Sugianli, 2, &ast Susantina Prodjosoewojo, 3 Yovita Hartantri, 3 Ida Parwati 2 1 Faculty of Medicine Universitas Padjadjaran, Bandung, Indonesia; 2 Department of Clinical Pathology Faculty of Medicine Universitas Padjadjaran/Dr. Hasan Sadikin General Hospital, Bandung, Indonesia; 3 Department of Internal Medicine, Faculty of Medicine Universitas Padjadjaran/Dr. Hasan Sadikin General Hospital, Bandung, Indonesia &astThese authors contributed equally to this work Correspondence: Adhi Kristianto Sugianli, Pasteur 38, Bandung ZIP 40161, Bandung, Indonesia, Tel +62 22 203 3307, Email Purpose: Coronavirus disease 2019 (COVID-19) is a new pandemic affecting the respiratory system and caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). In addition to the increased use of antibiotics, the length of stay of hospitalized patients affects the risk of bacterial infections among the COVID-19 patients. However, this pandemic has interrupted antibiotic surveillance activity and led to an information gap about the prevalence and characteristics of bacterial infection. This study aims to describe the antibiotic resistance in COVID-19 patients with culture-proven bacterial infection using a laboratory-based surveillance approach. Patients and Methods: A retrospective study with a cross-sectional design was conducted on adult patients that confirmed positive for COVID-19 according to the International Classification of Diseases 10th Revision (ICD-10). From March 2020 to October 2021, data were obtained from the hospital information system and merged with the culture and antibiotic susceptibility test from laboratory information system at Hasan Sadikin General Hospital. The outcome is the prevalence percentage of resistance to selected antibiotics in patients with COVID-19. The resistance percentage is considered high when equal to or more than 20%. Results: There was 2786 adult patient confirmed for COVID-19 according to the ICD-10, and 26.3% (n = 733) of them submitted clinical specimen for culture. The prevalence of bacterial infection among COVID-19 patients was 16.4%, predominating Gram-negative bacteria (GNB). The respiratory specimen dominated the positive growth culture. The GNB were predominantly discovered among the respiratory and non-respiratory specimens. High range resistance to ampicillin-sulbactam (24– 100%), ceftriaxone (22– 81%), cefotaxime (22– 73%) and ciprofloxacin (20– 86%) are observed among the GNB. Conclusion: There is high resistance to fluoroquinolone and cephalosporins in identified isolate, commonly used as the first-line empirical treatment for respiratory and non-respiratory infection in Indonesia. The continuous antibiotic surveillance is mandatory and crucial to prevent the long-term effects of the COVID-19 pandemic, particularly bacterial infection. Keywords: antibiotic resistance, bacterial infections, COVID-19, laboratory-based surveillance Coronavirus disease 2019 (COVID-19) is a new respiratory disease declared a pandemic in March 2020, and it is caused by a strain of coronavirus, severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). Furthermore, the pandemic has spread to many countries. 1 Starting from March 2020 until beginning of January 2022, there were 317.389.048 positive cases worldwide and 4.262.994 in Indonesia. Meanwhile, 709.204 cases were reported from West Java. 2 Dr. Hasan Sadikin General Hospital (RSHS) is a central hospital in this province with a maximum capacity of 1000 bed-inpatient. During the pandemic, RSHS changed its status to a COVID-19 referral hospital, which received an average of 291 patients per day. The clinical presentation of COVID-19 varies from mild to severe and is influenced by patient comorbidities, including diabetes mellitus and hypertension. 3 Previous studies identified problems with hospitalization and antibiotic usage in managing this virus. 4,5 The hospitalization rate due to this pandemic was as high as 10%, with an average length of stay (LOS) of 9 days, among those without bacterial infection. However, the high number of hospitalized patients and LOS contribute to an increased risk of hospital-acquired infections. 6 The other problem relates to antibiotic abuse during the COVID-19 pandemic, which affects bacterial resistance. Antibiotics are still prescribed in hospital settings for various reasons, despite that they are ineffective against the virus. The primary reasons for using antibiotics as an empirical treatment are the inability to differentiate between COVID-19 and bacterial infections in terms of -Abstract Truncated-

Antibiotic Resistance in COVID-19 with Bacterial Infection: Laboratory-Based Surveillance Study at Single Tertiary Hospital in Indonesia

Quantity of antibiotic use and its association with clinical outcomes in COVID-19 patients: A snapshot from a provincial referral hospital in Indonesia

Diagnostic and antibiotic use practices among COVID-19 and non-COVID-19 patients in the Indonesian National Referral Hospital

MDR Pathogens Organisms as Risk Factor of Mortality in Secondary Pulmonary Bacterial Infections Among COVID-19 Patients: Observational Studies in Two Referral Hospitals in West Java, Indonesia

Characterization of the Pathogen Distribution and Drug Resistance in Bloodstream Infections During COVID-19 Pandemic in a Tertiary Hospital in Eastern China: Comparison with the Pre-Pandemic Period

Pathogen Distribution, Drug Resistance Risk Factors, and Construction of Risk Prediction Model for Drug-Resistant Bacterial Infection in Hospitalized Patients at the Respiratory Department During the COVID-19 Pandemic

Prevalence of Empiric Antibacterial Therapy, Community-Acquired Bacterial Superinfection, and Antibiotic-Associated Adverse Reactions among Patients with COVID-19 Pneumonia Admitted in Makati Medical Center from March 2020 to March 2021

Antibiotic use in patients with Coronavirus disease 2019 (COVID-19): outcomes and associated factors

The Trend of Antibiotic Consumption After the COVID-19 Pandemic: Approach to Future Outbreaks

COVID-19 infection prevention and control for hospital workers in Indonesia

Factors associated with antibiotic resistance and survival analysis of severe pneumonia patients infected with Klebsiella pneumoniae, Acinetobacter baumannii, and Pseudomonas aeruginosa: A retrospective cohort study in Jakarta, Indonesia

A-288 Active Surveillance Cultures: Frequency of Microorganisms and Phenotypic Resistance Profile From Brazilian Public Hospitals After COVID-19 Pandemic Peak

Factors Associated to Community Practices Toward the COVID-19 Pandemic: A Cross-Sectional Study in Indonesia

Impact of the COVID-19 pandemic on antibiotic utilization in a tertiary hospital

Antimicrobial resistance (AMR) in COVID-19 patients: a systematic review and meta-analysis (November 2019-June 2021)

Analysis on Bacterial Distribution and Change of Drug Resistance Rate in ICUs Across Southwest China from 2018 to 2022

Exploring Antibacterial Usage and Pathogen Surveillance over Five Years in a Tertiary Referral Teaching Hospital Adult General Intensive Care Unit (ICU)

Characteristics and susceptibility pattern of catheter-associated urinary tract infections (CAUTI) bacteria in Indonesia: A study in a national reference hospital of Sumatra region 2020-2021

Incidence of multidrug-resistant, extensively drug-resistant and pan-drug-resistant bacteria in children hospitalized at Dr. Hasan Sadikin general hospital Bandung Indonesia

The pattern of antibiotic utilisation among intensive care unit patients hospitalised in a Gauteng (South African) provincial tertiary hospital: Comparing findings before and during COVID-19

Tracking Antibiotic Resistance Trends in Central Iran Amidst the COVID-19 Pandemic From 2021 to 2023: A Comprehensive Epidemiological Study